Dr Agarwal's Health Care Ltd Records Impressive Q3 Growth

Dr Agarwal's Health Care Ltd reported a Q3 profit of Rs 28.24 crore, up from Rs 22.59 crore last year. The company's nine-month profit reached Rs 67.79 crore, driven by robust revenue and patient growth. An IPO raised Rs 3,027 crore, facilitating expansion and technology investments.

Dr Agarwal's Health Care Ltd has announced a notable consolidated profit after tax of Rs 28.24 crore for the Q3 period ending December 2024, a significant increase from Rs 22.59 crore in the same quarter last year.

The company reported a profit after tax of Rs 67.79 crore over the nine months ending December 31, 2024, compared to Rs 53.73 crore in the prior year period. This growth was fueled by a revenue increase of 29.5% and an EBITDA rise of 26.3%, attributed to higher patient numbers and surgeries.

The IPO, post-December, raised Rs 3,027 crore, enabling the addition of 42 facilities within the April-December 2024 period. Dr Agarwal's equity shares are now listed on the BSE Ltd and NSE, enhancing its commitment to sustainable growth.